# Home Transfusion for HEME

> **NCT05509439** · NA · COMPLETED · sponsor: **Dana-Farber Cancer Institute** · enrollment: 10 (actual)

## Conditions studied

- Hematologic Malignancy

## Interventions

- **OTHER:** Home Transfusion Program Components

## Key facts

- **NCT ID:** NCT05509439
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-10-18
- **Primary completion:** 2025-05-13
- **Final completion:** 2025-05-21
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2025-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05509439

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05509439, "Home Transfusion for HEME". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05509439. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*